GlassScriptPhysician profile
Jacob H Rinker
NPI 1386939569
$21,131.17
in general payments reported to CMS, 2019-2025
20 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $733 · 2020: $2,800 · 2021: $85.80 · 2022: $689 · 2023: $11K · 2024: $5,064 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,500 · Travel and Lodging: $5,740 · Food and Beverage: $1,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,500.00 |
| Travel and Lodging | $5,739.86 |
| Food and Beverage | $1,583.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,305.50 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $4,795.65 | 2021-2025 | Abre, In.Pact Av, Venaseal |
| Medtronic Vascular, INC. | $1,610.83 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $1,237.66 | 2020-2021 | |
| Globus Medical, INC. | $611.34 | 2019 | |
| Enterra Medical, INC. | $111.96 | 2025 | |
| Philips North America LLC | $65.71 | 2024 | (9547) Igt Systems Undivided |
| Braintree Laboratories, INC. | $53.32 | 2019 | |
| Elucent Medical | $50.80 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $39.81 | 2025 | Exparel |
| Novo Nordisk INC | $35.74 | 2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $34.91 | 2025 | Zepbound, Mounjaro |
| Biocompatibles, INC. | $32.94 | 2019 | |
| Daiichi Sankyo INC. | $26.04 | 2024 | Injectafer |
| Inari Medical, INC. | $23.70 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $20.53 | 2025 | Miro3d |
| Amgen INC. | $20.27 | 2025 | Otezla, Repatha |
| Ethicon US, LLC | $19.38 | 2025 | Harmonic, Megadyne |
| Smith+Nephew, INC. | $17.55 | 2023 | Grafix Pl |
| Octapharma USA, INC. | $17.53 | 2025 | Fibryga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Rinker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.